🇺🇸 FDA

Intelligence · INN Directory

Pharmaceutical Drugs

Regulatory status, brand names, and pipeline context for BD, medical affairs, and competitive intelligence teams.

Drugs indexed
4,797
Companies
1,769
Pipeline programs
20,548

Quick answer

NovaPharmaNews tracks 4,797 pharmaceutical drugs by INN (International Nonproprietary Name), with US FDA approval status, brand names, originators, routes of administration, and links to pipeline programs and patents. Search by generic name or browse A–Z for competitive intelligence and medical affairs reference.

Showing page 72 of 200 · A–Z by INN

  1. etravirine

    INTELENCE Janssen-Cilag Pty Ltd

    ORAL FDA: approved · EMA: approved · TGA: approved

    J05AG04

  2. etretinate

    TEGISON

    ORAL FDA: approved

  3. etripamil

    CARDAMYST Milestone Pharmaceuticals

    NASAL FDA: approved

  4. etuvetidigene autotemcel

    WASKYRA

    EMA: approved

    B06

  5. eu-sourced

    NMPA: clinical trials

  6. eucalyptus oil (use as additive only)

    NULL

    TGA: approved

  7. evans blue

    EVANS BLUE

    INJECTION FDA: approved

  8. everolimus

    AFINITOR Novartis Pharmaceuticals

    ORAL FDA: approved · EMA: approved · TGA: approved

    L01XE10

  9. evinacumab

    EVKEEZA Ultragenyx UK Limited

    EMA: approved

    C10AX

  10. evinacumab-dgnb

    EVKEEZA Regeneron UK Limited

    INJECTION FDA: approved

  11. evocalcet

    ORKEDIA INITIAL APPROVAL

    PMDA: approved

  12. evolocumab

    REPATHA Amgen

    INJECTION FDA: approved · EMA: approved · TGA: approved · PMDA: approved · NMPA: clinical trials

    C10AX13

  13. ex vivo expanded autologous human corneal epithelial cells containing stem cells

    HOLOCLAR

    EMA: approved

    S01XA19

  14. exagamglogene autotemcel

    CASGEVY Vertex Pharmaceuticals (Australia) Pty.

    EMA: approved

    B06AX05

  15. exemestane

    APO-EXEMESTANE Pfizer Australia Pty Ltd

    ORAL FDA: approved · TGA: approved · NMPA: clinical trials

  16. exenatide

    BYDUREON

    EMA: approved · NMPA: clinical trials

    A10BJ01

  17. exenatide synthetic

    BYETTA Amneal Pharma Europe Ltd

    SUBCUTANEOUS FDA: approved

  18. exfoliated

    NMPA: clinical trials

  19. expansion

    NMPA: clinical trials

  20. experimental

    NMPA: clinical trials

  21. extended-release

    NMPA: clinical trials

  22. extracellular

    NMPA: clinical trials

  23. extremely-low

    NMPA: clinical trials

  24. eye drops containing cocaine hydrochloride

    NULL

    TGA: approved

Frequently asked questions

What is the NovaPharmaNews drugs directory?

It is a searchable index of 4,797 pharmaceutical active ingredients and their marketed profiles — INN, brand names, US regulatory status, manufacturers, and cross-links to clinical pipeline and patent records.

Where does drug approval data come from?

Profiles combine FDA Drugs@FDA and Orange Book references, ClinicalTrials.gov pipeline links, and editorial enrichment. See our data sources page for attribution and update cadence. This directory is for professional reference, not medical advice.

How do I find a drug by brand name?

Use the search box on this page — it matches both INN (generic name) and slug. Brand names appear on each drug row and on the full drug profile page, with links to the originator company when available.

Data attribution and licensing: Data sources